A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11)

American Journal of Gastroenterology

Volumn 106, Issue 9, 2011, Pages 1604-1611

  Lacy, Brian E ^a   Chehade, Robert ^a   Crowell, Michael D ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

48 H WIRELESS PH MONITORING; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROESOPHAGEAL REFLUX DISEASE QUESTIONNAIRE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT EXAMINATION; GENDER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PH MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM;

ADULT; AGED; AREA UNDER CURVE; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUESTIONNAIRES; ROC CURVE;

EID: 80052462128     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.180     Document Type: Article

References (50)

1. Shaheen NJ, Hansen RA, Morgan DR et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101: 2128-38. (Pubitemid 44337640)
2. Locke GR, Talley NJ, Fett SL et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56. (Pubitemid 27181367)
3. El-Serag HB, Petersen NJ, Carter J et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004; 126: 1692-9. (Pubitemid 38736334)
4. Ruigomez A, Garcia-Rodriguez LA, Wallander M-A et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004; 20: 751-60. (Pubitemid 39319230)
5. Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease. Pharm Res 2001; 18: 1367-72. (Pubitemid 32846334)
6. Dimenas E, Glise H, Hallerback B et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681-7. (Pubitemid 23231987)
7. Revicki DA, Wood M, Maton PN et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998; 104: 252-8. (Pubitemid 28163170)
8. Levin TR, Schmittdiel JA, Kunz K et al. Costs of acid-related disorders to a health maintenance organization. Am J Med 1997; 103: 520-8. (Pubitemid 28018655)
9. Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-11. (Pubitemid 34465190)
10. Moayyedi P, Talley NJ, Fennerty MB et al. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 2006; 295: 1566-76.
11. Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson-Dent gastroesophageal reflux disease questionnaire. Aliment Pharmacol Ther 2003; 17: 1049-55. (Pubitemid 36560805)
12. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205-8. (Pubitemid 20054587)
13. Moayyedi P, Axon ATR. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastro-oesphageal reflux disease. Am J Gastroenterol 1999; 94: 3122-5.
14. Locke GR, Talley NJ, Weaver AL et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47. (Pubitemid 24164694)
15. Shaw MJ, Talley NJ, Beebe TJ et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 52-7. (Pubitemid 32104807)
16. Elola-Olaso CM, Rey E, Rodriguez-Artalejo F et al. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Revista Espanola de Enfermedades Digestivas 2002; 94: 752-8. (Pubitemid 36157460)
17. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023-9. (Pubitemid 28505643)
18. Horowitz N, Moshkowitz M, Halpern Z et al. Applying data mining techniques in the development of a diagnostic questionnaire for GERD. Dig Dis Sci 2007; 52: 1871-8. (Pubitemid 47024648)
19. Ho KY, Gwee KA, Khor JL et al. Validation of a graded response questionnaire for the diagnosis of gastroesophageal reflux disease in an Asian primary care population. J Clin Gastroenterol 2008; 42: 680-6.
20. Jones R, Junghard O, Dent J et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 1030-8.
21. Lacy B, Chehade R, Crowell M. A prospective study to compare a symptom-based reflux disease questionnaire with Bravo pH capsule monitoring for the identification of gastroesophageal reflux disease. Am J Gastroenterol 2009; 104: S26.
22. Pandolfino JE, Richter JE, Ours T et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-9. (Pubitemid 36576296)
23. Lacy BE, O Shana T, Hynes M et al. Safety and tolerability of transoral Bravo capsule placement aft er transnasal manometry using a validated conversion factor. Am J Gastroenterol 2007; 102: 24-32. (Pubitemid 46072039)
24. Lacy BE, Weiser K, Chertoff J et al. The diagnosis of GER. Am J Med 2010; 123: 583-92.
25. Lacy BE, Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA 2008; 299: 555-65. (Pubitemid 351214253)
26. Lind T, Havelund T, Carlsson R et al. Heartburn without esophagitis: effi-cacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997; 32: 974-9. (Pubitemid 27433659)
27. Mantynen T, Farkkila M, Kunnamo I et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 2002; 97: 2524-9. (Pubitemid 35153463)
28. Kahrilas PJ, Quigley EMM. American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording . Gastroenterology 1996; 110: 1981-96.
29. Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102: 668-85. (Pubitemid 46328165)
30. Sifrim D, Castell D, Dent J et al. Gastroesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid and gas reflux. Gut 2004; 53: 1024-31. (Pubitemid 38824163)
31. Wong WM, Lam KF, Lai KC et al. A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-esophageal reflux disease in the Chinese population. Aliment Pharmacol Ther 2003; 17: 1407-13. (Pubitemid 36774148)
32. Wang JH, Luo JY, Dong L et al. Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease. World J Gastroenterol 2004; 10: 3332-5. (Pubitemid 39585476)
33. Chinese Study Group. Value of reflux diagnostic questionnaire in the diagnosis of gastroesophageal reflux disease. Chinese J Dig Dis 2004; 5: 51-5.
34. Shimoyama Y, Kusano M, Sugimoto S et al. Diagnosis of gastroesophageal reflux disease using a new questionnaire. J Gastroenterol Hepatol 2005; 20: 643-7. (Pubitemid 40755281)
35. Kinekawa F, Kubo F, Matsuda K et al. Is the questionnaire for the assessment of gastroesophageal reflux useful for diabetic patients? Scand J Gastroenterol 2005; 40: 1017-20. (Pubitemid 41291349)
36. Hung CS, Lee CL, Yang JN et al. Clinical application of Carlsson's questionnaire to predict erosive GERD among healthy Chinese. J Gastro Hepatol 2005; 20: 1900-95.
37. Shaw M, Dent J, Beebe T et al. The reflux disease questionnaire: a measure for treatment response in clinical trials. Health Qual Life Outcomes 2008; 6: 31-40.
38. Revicki D, Wood M, Wiklund I et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastro-oesophageal reflux disease. Qual Life Res 1998; 7: 75-83. (Pubitemid 28113967)
39. Jones R, Coyne K, Wiklund I. The gastroesophageal disease impact scale: a patient management tool for primary care. Aliment Pharm Ther 2007; 25: 1451-9. (Pubitemid 46848895)
40. Dent J, Vakil N, Jones R et al. Validation of the reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease in primary care. Gut 2007; 56 (Suppl 111): 328.
41. Nataskin I, Mehdikhani E, Conklin J et al. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006; 51: 2113-20.
42. Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100: 283-9. (Pubitemid 40314510)
43. Hirano I, Zhang Q, Pandolfino JE et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005; 3: 1083-8. (Pubitemid 41565373)
44. Hemmink GJM, Bredenoord AJ, Weusten BLAM et al. Esophageal pHimpedance monitoring in patients with therapy-resistance reflux symptoms: " on " or " off " proton pump inhibitor? Am J Gastroenterol 2008; 103: 2446-53.
45. Pritchett JM, Aslam M, Slaughter JC et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and offtherapy. Clin Gastroenterol Hepatol 2009; 7: 743-8.
46. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402. (Pubitemid 44476780)
47. Sharma N, Agrawal A, Freeman J et al. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol 2008; 6: 521-4.
48. Iwakiri K, Kawami N, Sano H et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 2009; 44: 708-12.
49. Wong WM, Bautista J, Dekel R et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring-a randomized trial. Aliment Pharmacol Ther 2005; 21: 155-63. (Pubitemid 40222968)
50. Wenner J, Johnsson F, Johansson J et al. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007; 102: 239-45. (Pubitemid 46160535)